May 9, 2020

ObsEva Annual General Meeting 2020

Email Print Friendly Share   Geneva, Switzerland and Boston, MA – May 8, 2020 – ObsEva SA (NASDAQ: OBSV / SIX: OBSN), a clinical-stage biopharmaceutical company focused on the development and commercialization...
Read More →